Showing results (361-370 of 773) with videos related to
Sort By:
Pageof 78
The Journal of Clinical and Aesthetic Dermatology|June 18, 2016
Fixed Combination Aerosol Foam Calcipotriene 0.005% (Cal) Plus Betamethasone Dipropionate 0.064% (BD) is More Efficacious than Cal or BD Aerosol Foam Alone for Psoriasis Vulgaris: A Randomized, Double-blind, Multicenter, Three-arm, Phase 2 StudyMark Lebwohl, Stephen Tyring, Michael Bukhalo, et al.American Family Physician|May 22, 2004
Diagnosis and treatment of acneSteven Feldman, Rachel E Careccia, Kelly L Barham, et al.Journal of Drugs in Dermatology : JDD|April 7, 2023
Patient Preferences in Topical Psoriasis TreatmentAlyssa Curcio, Christina Kontzias, Brandon Gorodokin, et al.Journal of Drugs in Dermatology : JDD|August 10, 2022
Unmet Needs in Psoriasis PatientsCaroline Porter, Alexander Woods, Madeleine Mendelow, et al.Dermatology Online Journal|October 31, 2025
Utilizing artificial intelligence to address dermatology curriculum deficiencies in pre-clinical medical educationLauren McGrath, Melanie Rodriguez, Maria Mariencheck, et al.Journal of Drugs in Dermatology : JDD|March 6, 2023
Trends in Oral Antibiotic Use for Acne Treatment: A Retrospective, Population-Based Study in the United States, 2014 to 2016Ayman Grada, April Armstrong, Christopher Bunick, et al.Journal of the American Academy of Dermatology|September 1, 2025
Real-world treatment patterns in patients with generalized pustular psoriasis (GPP)Bruce Strober, Hannah Kwiatkowski, Layla Lavasani, et al.Journal of the American Academy of Dermatology|April 18, 2015
Evaluating the economic burden of psoriasis in the United StatesJacqueline Vanderpuye-Orgle, Yang Zhao, Jackie Lu, et al.Archives of Dermatology|June 18, 2003
An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasisMark Lebwohl, Enno Christophers, Richard Langley, et al.Archives of Dermatology|July 20, 2005
No evidence for increased risk of cutaneous squamous cell carcinoma in patients with rheumatoid arthritis receiving etanercept for up to 5 yearsMark Lebwohl, Robin Blum, Eric Berkowitz, et al.Pageof 78